Daily Archives

February 13, 2015

Fenway Institute To Serve As Testing Site For Innovative HIV Vaccine Studies

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute, Uncategorized | No Comments
Since the 1980s, Fenway Health has been a leader in HIV/AIDS prevention research and education. In that tradition, The Fenway Institute will soon serve as a site for two upcoming vaccine studies that have the potential to significantly reduce the number of new HIV infections: HVTN 106 and HVTN 110. HVTN 106 The first study, HVTN 106, will test four experimental vaccines against HIV by using DNA “primes” – DNA that can replicate the proteins found in HIV. The study vaccines are called DNA Nat-B env, DNA CON-S env, DNA Mosaic env, and MVA-CMDR. It’s important to note that the  
Read More